- Authors:
-
Esposito, Maria; Gisondi, Paolo; Assorgi, Chiara; Bellinato, Francesco; Brianti, Pina; Burlando, Martina; Brunasso, Giovanna; Caccavale, Stefano; Caldarola, Giacomo; Campione, Elena; Calzavara Pinton, Piergiacomo; Campanati, Anna; Giovanni Carrera, Carlo; Carugno, Andrea; Cozzani, Emanuele; Costanzo, Antonio; Cusano, Francesco; Dapavo, Paolo; Dattola, Annunziata; De Simone, Clara; Di Caprio, Roberta; Diotallevi, Federico; Concetta Fargnoli, Maria; Gaiani, Francesca; Giunta, Alessandro; Malagoli, Piergiorgio; Valerio Marzano, Angelo; Megna, Matteo; Rafaele Mercuri, Santo; Mortato, Edoardo; Narcisi, Alessandra; Orsini, Diego; Potestio, Luca; Quaglino, Pietro; Giovanni Richetta, Antonio; Romano, Francesca; Sena, Paolo; Vagnozzi, Emanuele; Venturini, Marina; Loconsole, Francesco; Balato, Anna
- Title:
-
Super Responder Profle Under Bimekizumab Treatment
in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life
Observation—IL PSO (Italian Landscape Psoriasis)
- Year:
-
2025
- Type of item:
-
Articolo in Rivista
- Tipologia ANVUR:
- Articolo su rivista
- Language:
-
Inglese
- Referee:
-
No
- Name of journal:
- Clinical Drug Investigation
- ISSN of journal:
- 1173-2563
- Page numbers:
-
1-7
- Keyword:
-
There is still a lack of knowledge on the characteristics of super responders (SRs) during treatment with bimeki- zumab, since genetic, clinical, and biomarkers investiga- tions are required. During bimekizumab treatment, a high rate of SRs was demonstrated at early clinical timepoints, with some interesting diferences between SRs and non-super- respnders.
- Short description of contents:
- There is still a lack of knowledge on the characteristics
of super responders (SRs) during treatment with bimeki-
zumab, since genetic, clinical, and biomarkers investiga-
tions are required.
During bimekizumab treatment, a high rate of SRs was
demonstrated at early clinical timepoints, with some
interesting diferences between SRs and non-super-
respnders.
- Product ID:
-
145884
- Handle IRIS:
-
11562/1162653
- Last Modified:
-
May 21, 2025
- Bibliographic citation:
-
Esposito, Maria; Gisondi, Paolo; Assorgi, Chiara; Bellinato, Francesco; Brianti, Pina; Burlando, Martina; Brunasso, Giovanna; Caccavale, Stefano; Caldarola, Giacomo; Campione, Elena; Calzavara Pinton, Piergiacomo; Campanati, Anna; Giovanni Carrera, Carlo; Carugno, Andrea; Cozzani, Emanuele; Costanzo, Antonio; Cusano, Francesco; Dapavo, Paolo; Dattola, Annunziata; De Simone, Clara; Di Caprio, Roberta; Diotallevi, Federico; Concetta Fargnoli, Maria; Gaiani, Francesca; Giunta, Alessandro; Malagoli, Piergiorgio; Valerio Marzano, Angelo; Megna, Matteo; Rafaele Mercuri, Santo; Mortato, Edoardo; Narcisi, Alessandra; Orsini, Diego; Potestio, Luca; Quaglino, Pietro; Giovanni Richetta, Antonio; Romano, Francesca; Sena, Paolo; Vagnozzi, Emanuele; Venturini, Marina; Loconsole, Francesco; Balato, Anna,
Super Responder Profle Under Bimekizumab Treatment
in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life
Observation—IL PSO (Italian Landscape Psoriasis)
«Clinical Drug Investigation»
,
2025
,
pp. 1-7
Consulta la scheda completa presente nel
repository istituzionale della Ricerca di Ateneo 
